AZAFAROS

HQ - Naarden

Summary

Azafaros is a clinical-stage biotechnology company treating rare lysosomal storage disorders with oral small molecules, including nizubaglustat.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 111 M

Avg. Deal Size£ 111 M

Market Context

Senior Management